Humacyte Inc.-CW27HUMAWPreferred / convertible

13F holders, Q1 2025 (March 31)
5holders
1new positions
1sold out
$0.37avg. 13F price*

At the end of Q1 2025, 5 institutions reported holding Humacyte Inc.-CW27 (HUMAW) in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were LPL Financial LLC ($103K), Jane Street Group, LLC ($19K) and Sio Capital Management, LLC ($18K).

Company
Humacyte Inc.-CW27
CUSIP
44486Q111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q1 2024: 6Q1 2024Q2 2024: 10Q2 2024Q3 2024: 7Q3 2024Q4 2024: 5Q4 2024Q1 2025: 5Q1 2025Q2 2025: 6Q2 2025Q3 2025: 6Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions1$4K
Exits1$22K

All 13F filers, Q4 2024 → Q1 2025: 13,436 shares bought and 31,350 shares sold, net −17,914 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 5 holders

LPL Financial LLC — Reduce -6.5% 279,115 $103K
Jane Street Group, LLC — No change 50,000 $19K
Sio Capital Management, LLC — No change 49,998 $18K
Wolverine Asset Management LLC — Add +8.3% 34,711 $13K
Susquehanna International Group, LLP — New 10,760 $4K

"% of holder's portfolio" is HUMAW's weight in each manager's 13F, not the share of Humacyte Inc.-CW27 the manager owns.